MGI Launches 'ZhiYiHui' Online Information Sharing Platform to Empower Multi-Domain, End-to-End Solutions with Ecosystem Partners

VCBeat learned that on May 28, 2023, at the 20th China Association of Clinical Laboratory Practice (CACLP) Expo for Clinical Laboratory Medicine and Transfusion Instruments and Reagents,MGI Grandly Launches “Zhiyihui” Online Information-Sharing Platform, Offering a One-Stop Showcase of Application Solutions Based on MGI’s Tool Platform and Aggregating MGI’s Full Product Portfolio Alongside Compatible Third-Party Products, by enriching end-user choices, to promote the expansion of application scenarios and fields.This is the first information-sharing platform in China’s gene sequencing industry to integrate an ecosystem, marking another solid step by MGI in building a digital and intelligent ecosystem. Collaborative cooperation and bundled applications will reach new heights.

“Zhiyi Hui” Online Information Sharing Platform showcases MGI’s end-to-end product portfolio based on the MGI Tools Platform across various application fields. It aggregates third-party products compatible with the DNBSEQ sequencing platform, ranging from instruments and equipment to reagents, consumables, and analysis software, providing end users with diverse application solutions that meet the needs of numerous scenarios, including scientific research, clinical medicine, and emerging applications.

To truly maximize the utility of its tools and broaden their applications, MGI provides interactive service support and collaborates with ecosystem partners on application development based on the DNBSEQ sequencing platform.“Zhiyi Hui” Online Information Sharing Platform enables efficient information transmission and sharing, integrates products, technologies, and expertise from multiple fields, facilitates the compatibility of MGI’s tool platform with third-party products, and provides users with a more precise and highly operational one-stop product portfolio.

Currently,Nearly 50 products from more than 20 third-party brands worldwide will be listed on the “Zhiyihui” online information-sharing platform, with its China site going live on the same day. Representatives of the first six ecosystem partners to join the platform—Roche Diagnostics, Ushenkon, Raynmed, Bingyuan Medical, Geneseeq, and IDT Edite—jointly witnessed the platform’s launch and go-live at the conference venue.

From left to right: Lin Siyuan, Director of the Business Development Center at MGI; Fu Yunbin, Head of Marketing at IDT; Yu Dehua, General Manager and Chief Scientist at UcanGene; Tian Zhiqiang, Senior Marketing Director of Life Science at Roche Diagnostics; Zhu Wei, Head of New Business in China at MGI; Zhang Lucheng, Head of Industry and Overseas Business Lines at Genetron Health; Li Shaochuan, CTO at Reain Medical; Pu Hao, CEO at Bingyuan Medical; Zhang Xu, CEO at Reain Medical; Lei Ying, Director of Product Marketing in China at MGI

In the future, MGI will also plan to launch more regional sites for its “Zhiyihui” online information-sharing platform in the global market and continue to introduce third-party brands and products.

MGI has achieved full coverage of high-, medium-, and low-throughput capabilities across its product portfolio—including gene sequencers, automation systems, biobanks, and BIT solutions—centered on “storage, reading, computing, and application,” thereby providing the life sciences industry with core technological tools. To facilitate the industry’s transition from mere tool provision to a comprehensive ecosystem, MGI is committed to building an intelligent digital ecosystem that integrates software and hardware, having previously launched its Smart Lab System.

The Zhihui Laboratory System integrates tools such as IoT and flexible robotics, leveraging MGI’s extensive experience and innovative technologies in the field of life digitalization to provide users with comprehensive laboratory information and digital management solutions across multiple scenarios and applications.Based on actual needs and usage scenarios, Zhihui Laboratory can provide customized product portfolios for each user, efficiently compatible with users' existing equipment while fully integrating third-party devices to create a digital-intelligent ecosystem for life science "hardware."

To enhance the user experience of its one-stop product portfolio, MGI has developed a packaged deployment solution for laboratory application apps, leveraging the device IoT interaction capabilities of the Smart Lab. These laboratory application apps integrate laboratory operational procedures across various application domains, consolidating end-to-end experimental SOPs—from sample to report—into standalone apps.By installing a dedicated experimental application, users can conveniently deploy experimental procedures—including full-process operational manuals, equipment runtime scripts, and information system code integration—thereby building a digital-intelligent ecosystem for life science “software.”

Thus, MGI, through the integration of“Zhiyihui” online information sharing platform, Laboratory Application APP deployment software, and Zhihui Laboratory System have jointly built an open, flexible, and sustainable digital-intelligent ecosystem for life sciences that integrates hardware and software, propelling the life sciences industry into a new phase of ecological development.

Tian Zhiqiang, Senior Marketing Director, Life Science Division, Roche Diagnostics

Tian Zhiqiang, Senior Marketing Director of Roche Diagnostics Life Science Division“MGI continues to pursue independent innovation, leading the revolution in domestically produced sequencers and promoting the application of sequencing in scientific research and medicine, thereby facilitating the widespread accessibility of genomic technology. With the launch of the ‘Zhi Yi Hui’ online information-sharing platform, Roche Diagnostics, as one of the first ecosystem partners to join, looks forward to working with MGI to drive the development of the genetic testing industry and jointly build a new ecosystem for life and health.”

Youshengkang General Manager and Chief Scientist: Yu Dehua

Yu Dehua, General Manager and Chief Scientist of U-Saint Health“MGI’s Smart Lab has significantly improved the efficiency of genetic testing, greatly promoting the development of the life sciences industry. The newly launched ‘Zhiyi Hui’ online information-sharing platform is poised to further empower the genetic testing sector. As one of the first ecosystem partners to join the platform, Ushengkang will leverage its advantages in end-to-end product integration to make precision oncology genetic testing accessible to more patients.”

Ruiyin Maituo CTO: Li Shaochuan

Li Shaochuan, CTO of RayInMedTech“We look forward to MGI’s ‘Zhiyi Hui’ online information-sharing platform becoming a leading exemplar of the new integrated industrial ecosystem, guiding upstream and downstream partners in delivering higher-quality, more professional technologies and services, enabling a broader user base to experience the platform’s power in integrating upstream and downstream resources, and making infectious disease diagnostics more precise and simpler!”

Bingyuan Medical CEO: Pu Hao

Pu Hao, CEO of Bingyuan Medical: “Bingyuan Medical partners with MGI’s ‘Zhi Yi Hui’ online information-sharing platform, looking forward to intelligent sequencing, targeted specificity, and the convergence of medical diagnostics! Together, we stand in China and go global, making precision medicine accessible to all!”

Gene+ Head of Industry and Overseas Business Lines: Zhang Lucheng

Zhang Lucheng, Head of Industry and Overseas Business at Genetron Health“As a close partner of MGI, Genetron Health has been committed to providing domestic and international customers with rapid, implementable total solutions for oncology and pathogens based on the DNBSEQ platform. The launch of the ‘Zhiyi Hui’ online information-sharing platform will establish an efficient ecosystem model. We hope to work together with MGI to make positive contributions to improving global healthcare standards!”

IDT Integrated DNA Technologies: Fu Yunbin, Head of Marketing

Fu Yunbin, Head of Marketing at IDT“IDT is committed to partnering with MGI to refine adaptation solutions for MGI’s sequencing platforms, creating end-to-end workflows for high-throughput sequencing that span from library preparation to targeted capture. The launch of the ‘Zhi Yi Hui’ online information-sharing platform aligns with emerging trends in digital development, integrating a premium and comprehensive portfolio of ecosystem products to deliver convenient and efficient solutions. IDT and MGI look forward to joining forces with all stakeholders to ‘intelligently’ build a better future.”

At this CACLP, MGI also unveiled its full suite of core life science tools, including multiple gene sequencers such as the DNBSEQ-T20×2, which recently broke records for throughput and cost per sample, as well as the DNBSEQ-T7, DNBSEQ-G99, and DNBSEQ-E25. The showcase featured various products from its laboratory automation line, such as the DNBelab-D4 Digital Sample Preparation System and the MGISP-Smart 8 Automated Sample Preparation System, along with new business offerings like the MGICLab-LT Ultra-Low Temperature Automated Biobank and the Smart Lab.

Meanwhile, MGIIt introduces its financial leasing business, providing downstream users who need to procure equipment or upgrade products with an optional pathway to alleviate cash flow pressure, thereby empowering more users with core life science tools.Additionally,The AR fusion display technology showcased at the MGI booth also attracted many attendees.Through AR technology, viewers can directly view multiple sequencers and automated equipment on tablets, and conduct 3D simulated operation demonstrations, as if they were present in the sequencing laboratory, achieving real-time interaction with MGI's latest core life science tools.

As of December 31, 2022, MGI’s business presence spanned more than 90 countries and regions across six continents, serving a cumulative total of over 2,000 users worldwide. Committed to becoming the “Creator of Core Tools for Life Science Technology,” MGI focuses on providing real-time, comprehensive, full-lifecycle life digitalization equipment and systems through independent research and development. Driven by innovation, MGI fosters open collaboration, empowers the downstream ecosystem, accelerates the expansion of application scenarios, and deepens its global market layout. Through continuous innovation and cooperation, MGI aims to harness the collective strength of the industry ecosystem, ensuring that its tools truly empower users, provide greater support for industry development and technological breakthroughs, and make significant contributions to Earth’s biodiversity and human health.